Form 8-K

 

SECURITIES AND EXCHANGE COMMISSION  

WASHINGTON, DC 20549

 


 

FORM 8-K

 

Current Report Pursuant to Section 13 or 15(d) of  

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):    August 25, 2003

 


 

Kewaunee Scientific Corporation

(Exact name of registrant as specified in its charter)

 

Delaware   0-5286   38-0715562
(State or other jurisdiction of
incorporation or organization)
  (Commission File
Number)
  (IRS Employer
Identification No.)

 

2700 West Front Street 

Statesville, NC 28677

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (704) 873-7202

 

N/A

(Former name or former address, if changed since last report)

 


 



Item 7.    Financial   Statements and Exhibits.

 

(c)   Exhibits.

 

Exhibit Number

  

Description of Exhibit


99.1

  

Press Release, dated August 25, 2003, of Kewaunee

Scientific Corporation, announcing its first quarter earnings.

 

Item 9.    Regulation   FD Disclosure (Information is Being Provided Under Item 12).

 

On August 25, 2003, Kewaunee Scientific Corporation (the “Company”) issued a Press Release announcing its first quarter earnings. The Press Release is incorporated herein by reference, and is included as Exhibit 99.1 to this Current Report on Form 8-K.

 

Exhibit 99.1 to this report contains information regarding a non-recurring gain incurred by the Company. For comparative purposes, following the disclosure of the Company’s net earnings in Exhibit 99.1 which includes the applicable non-recurring gain, the Company has reported the impact on net earnings resulting from the non-recurring gain, such additional information constituting a “non-GAAP financial measure” as defined in Item 10 of Regulation S-K of the Securities Exchange Act of 1934, as amended. The Company has included this additional information because it believes that the disclosure of such information is useful for comparing the Company’s results of operations to prior periods.

 

The information furnished under “Item 9. Regulation FD Disclosure” is intended to be furnished under “Item 12. Results of Operations and Financial Condition” in accordance with SEC Release No. 33-8216. The information in this Form 8-K and the exhibit attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Page - 1


SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: August 25, 2003

 

Kewaunee Scientific Corporation

 
 

By:

 

/s/    D. Michael Parker        


   

D. Michael Parker

Senior Vice President, Finance and
Chief Financial Officer

 

Page - 2